Skip to main content
Premium Trial:

Request an Annual Quote

Lucigen Receives $300K Investment, Seeks Additional Funds to Qualify for NSF Matching Grant

NEW YORK, Jan. 20 (GenomeWeb News) - Lucigen of Middleton, Wis., has received $300,000 in initial funding from undisclosed investors, the company said today.

 

Lucigen said it is seeking an additional $200,000 in equity financing in order to qualify for a matching grant from the National Science Foundation that would bring its total funding to $1 million.

 

The company plans to use the funds to expand the manufacturing and marketing capabilities for its gene cloning products and its proprietary Single Cell Genomics technology, which it uses to discover new, commercially valuable enzymes in extremophiles.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.